Technology News and Research

RSS

Scientists explore biodegradable nanomedicine to destroy ovarian cancer cells left behind after surgery

Scientists are investigating a biodegradable nanomedicine that can selectively destroy ovarian cancer cells left behind after surgery. These findings are a step forward in the development of targeted therapies for hard-to-treat cancers. This work is being presented Oct. 29 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.

29 Oct 2015

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, and Arcturus Therapeutics, Inc., a leading RNA medicines company, today announced that they have entered into a research collaboration and license agreement to discover and develop messenger RNA (mRNA) therapeutics to certain rare disease targets using Arcturus' UNA Oligomer chemistry and LUNAR nanoparticle delivery platform.

29 Oct 2015

University of Surrey-led study reveals causes of Delhi's pollution problems

A new study "Air Pollution Challenges for developing megacities like Delhi" published today in Atmospheric Environment has described how Delhi suffers a toxic blend of geography, growth, poor energy sources and unfavourable weather that perpetuates and propagates its dangerously high levels of air pollution.

29 Oct 2015

New heart-powered pacemakers may be on the horizon

The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.

29 Oct 2015

Scientists call for coordinated effort to drive cutting edge microbiome research

A consortium of 48 scientists from 50 institutions in the United States - including Pamela Silver, Ph.D., a Core Faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University - are calling for a Unified Microbiome Initiative that would span national cross-institutional and cross-governmental agency support.

29 Oct 2015

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

Dementia specialists and PET imaging providers can now register to participate in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study at Ideas-Study.org.

29 Oct 2015

New technique may enable in-flight detection of hypoxia in pilots

Researchers working in the United States have demonstrated a technique that may enable real-time, in-flight detection of hypoxia in pilots.

29 Oct 2015

Upstream Medical Technologies formed to revolutionise accurate diagnosis of heart conditions

A new company that could revolutionise the accurate diagnosis of heart conditions was launched in Christchurch, New Zealand today.

29 Oct 2015

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

A radiotherapeutic bandage is being evaluated by researchers for efficacy against squamous cell carcinoma (SCC) in an animal model. These results could confirm the viability of a new and improved strategy for the radiotherapeutic treatment of skin cancer in the clinic. This work is being presented Oct. 28 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.

29 Oct 2015

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

For about the last 25 years, the cardiology group here have been developing a platform technology for both the diagnosis and treatment of atherosclerosis.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 28 Oct 2015

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

The ‘two week wait’ referral was brought into England in 2000. If a patient goes to see their GP and they meet specific criteria that cause the GP to think they might have cancer, then they should be referred to see a specialist within two weeks.

28 Oct 2015

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Today, IMBRUVICA (ibrutinib) was awarded the prestigious Prix Galien USA 2015 Award in the category of Best Pharmaceutical Agent. The Prix Galien Award is considered to be the industry's highest accolade and recognizes the vital technical, scientific and clinical research skills necessary to develop medicines.

28 Oct 2015

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Cynosure, Inc. today announced that it has received a medical device license issued by Health Canada to market MonaLisa Touch® for the treatment of symptoms related to Genitourinary Syndrome of Menopause (GSM), including vaginal dryness, vaginal burning, vaginal itching, pain, dysuria and dyspareunia.

28 Oct 2015

Multimodal non-invasive neurological monitoring reduces postoperative delirium in older cardiac patients

Patients undergoing cardiac surgery are at an increased risk of developing delirium and other changes in cognitive function in the days following surgery. However, new research presented at the ANESTHESIOLOGY 2015 annual meeting, found using monitors to track depth of anesthesia and oxygenation levels in older patients' brains during cardiac surgery significantly reduced their incidence of postoperative delirium and associated cognitive decline.

28 Oct 2015

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

For UK-based Paxman – pioneers in scalp cooling – October is a poignant month. Not only is it Breast Cancer Awareness Month but it also marks fifteen years since the loss of Sue Paxman; the inspiration behind the scalp cooler.

From Paxman 28 Oct 2015

FDA approves Endo’s BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

28 Oct 2015

New, simpler surgical intervention not better than old method for treatment of intestinal perforation

A new and simpler surgical method for the treatment of intestinal perforation is a poorer alternative for patients compared to the old method, researchers at the University of Oslo and Akershus University Hospital find. The study raises important questions about the testing of new surgical methods.

28 Oct 2015

UCLA launches second Grand Challenge to reduce health and economic impacts of depression

In an effort to place depression front and center on the national and international research agendas, UCLA has launched the Depression Grand Challenge, which aims to reduce the health and economic impacts of depression by half by the year 2050.

28 Oct 2015

New method to grow 3D pancreatic cancer organoid may help test drug responses and personalized treatments

The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and personalizing treatments in a rapid, cost-effective manner.

28 Oct 2015

Wyss Institute, UMass team up to develop drug-device combination for treating blood clots in stroke patients

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University developing novel nanotherapeutics for clearing obstructed blood vessels have teamed up with researchers at University of Massachusetts' New England Center for Stroke Research (NECSTR) to develop a new, highly effective drug-device combination for treating life-threatening blood clots in patients with stroke.

28 Oct 2015

Technology News and Research

Scientists explore biodegradable nanomedicine to destroy ovarian cancer cells left behind after surgery

Ultragenyx, Arcturus sign agreement to develop mRNA therapeutics to certain rare diseases

University of Surrey-led study reveals causes of Delhi's pollution problems

New heart-powered pacemakers may be on the horizon

Scientists call for coordinated effort to drive cutting edge microbiome research

Dementia specialists, PET imaging providers can now register to participate in IDEAS Study

New technique may enable in-flight detection of hypoxia in pilots

Upstream Medical Technologies formed to revolutionise accurate diagnosis of heart conditions

New radiotherapeutic bandage shows promise against squamous cell carcinoma in animal model

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

IMBRUVICA (ibrutinib) wins Prix Galien USA 2015 Award in Best Pharmaceutical Agent category

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Multimodal non-invasive neurological monitoring reduces postoperative delirium in older cardiac patients

Paxman donates scalp cooling system to Huddersfield Royal Infirmary to raise awareness of breast cancer

FDA approves Endo’s BELBUCA (buprenorphine) buccal film for use in patients with chronic pain

New, simpler surgical intervention not better than old method for treatment of intestinal perforation

UCLA launches second Grand Challenge to reduce health and economic impacts of depression

New method to grow 3D pancreatic cancer organoid may help test drug responses and personalized treatments

Wyss Institute, UMass team up to develop drug-device combination for treating blood clots in stroke patients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News